Agouron Pharmaceuticals (AGPH) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Agouron Pharmaceuticals (AGPH)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
6136	24	0	AGPH

Emcee: Bhag Karamchandani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
5461	nord, Rick raised the issue of a possible DD deal quite a number of months ago	Peter Singleton	-	10/5/1998
5460	While I introduced the concept of a DuPont suitor richard to whom did you int	nord	-	10/5/1998
5459	>> Why be taken out now? << While I introduced the concept of a Du	scaram(o)uche	-	10/5/1998
5458	Margie Couldn't agree more. Why be taken out now? Why spin off oncology si	nord	-	10/5/1998
5457	I don't think the rights transfer with the shares. I thought that only thos	margie	-	10/5/1998
5456	Doug, my understanding is that the rights transfer with the shares, and will co	John Metcalf	-	10/5/1998
5455	Doug: Business is business. The rights are to protect the company from an unf	billkirn	-	10/5/1998
5454	SEQU has been acquired by AZA. So there is buying going on in the biotech indus	Izzy	-	10/5/1998
5453	Questions on shareholder rights - 1) aren't the rights held only by shareho	Doug Markle	-	10/5/1998
5452	John: I don't think AGPH will sell out any time soon. They may consider a	billkirn	-	10/5/1998
5451	My guess is that AGPH will seriously consider being acquired if (1) the price i	sam	-	10/4/1998
5450	DuPont expects to net in excess of $3B from selling a fraction of Conoco to the	John Metcalf	-	10/4/1998
5449	Agouron called tempting target for drug giants By Thomas Kupper STAFF WRITE	Steve Fancy	-	10/4/1998
5448	"Haven't we heard of the scenario? We invented it." Let's gi	sam	-	10/3/1998
5447	Izzy: Haven't we heard of the scenario? We invented it. Rick	scaram(o)uche	-	10/3/1998
5446	This will give you something to think about today. Buyout of AGPH is probably i	Izzy	-	10/3/1998
5445	Well, pretty impressive, to hear Dr. Calvin Cohen, Research Director of Communi	margie	-	10/2/1998
5444	Here's one for all of you lurking analysts, reporters, and McC's that l	scaram(o)uche	-	10/2/1998
5443	Izzy, you need Adobe Acrobat and a later model netscape or IE browser. Belo	Steve Fancy	-	10/2/1998
5442	Is the $48/sh before or after AGPH buys out IMNR? The link is not going thru fo	Izzy	-	10/1/1998
5441	Here's a link to the 9/21 Lehman report I found on Yahoo. Bullish repor	Steve Fancy	-	10/1/1998
5440	Elise Wang & Paine Weber are having a conference call this afternoon: An up	margie	-	10/1/1998
5439	Special Biotechnology edition of The Wall Street Transcript	Steve Fancy	-	10/1/1998
5438	[OT] Bill: Ever suggest shorting the indices the day before Greenspan speaks? S	Izzy	-	10/1/1998
5437	I see the news quoted below as strongly increasing demand for HIV treatment nex	Joe E.	-	9/30/1998

Go to reply# or date (mm/dd/yy):